With the Cannabis Industry Trading Ultra-Cheap, Organigram Stock Looks Like a Screaming Buy!

After selling off for years, Organigram stock now offers tonnes of value and is easily one of the best cannabis stocks to buy now.

| More on:
Pot stocks are a riskier investment

Image source: Getty Images

For years, pot stocks were some of the best and most popular growth stocks that investors could buy. Leading up to legalization, cannabis stocks saw insane growth in their share prices. And while it wasn’t the top performer, even a company like Organigram (TSX:OGI)(NASDAQ:OGI) and its stock price grew by over 400% from August 2017 to May 2019.

Organigram stock

But as I and many of my fellow Fools warned investors at the time, the cannabis sector would likely take years to reach profitability and was almost sure to have several significant growing pains.

Although many stocks rallied rapidly, it was clear that the growth the industry would achieve would take a lot longer than many expected. So, after pot stocks reached hefty valuations and the growth in sales failed to keep up, these stocks have been selling off consistently for years now.

The first selloff came soon after legalization, which can be attributed to the speculative buying leading up to that point and the massive valuations many pot stocks, including Organigram stock, had.

However, the selloff has continued in recent years, as sales growth has slowed for many of these companies, and consistent profitability is still a ways off for many in the industry.

And now, with highly uncertain and risk-averse market conditions, it’s no surprise that these long-term, higher-growth stocks continue to lose value.

But while the industry has faced numerous headwinds and growing pains in recent years, it can’t sell off forever. At some point, after selling off for so many years, these stocks will begin to offer value.

Are cannabis stocks worth a buy today?

Nearly four years after cannabis was legalized in Canada, many of the largest and best-known stocks continue to struggle to break even. Most are still growing revenue. However, with significant competition, both from other companies and the black market, the industry continues to face significant headwinds.

One of the reasons Organigram is so attractive is that it’s cheaper than many of its competitors, has been growing well, and is much closer than many of its competitors to reaching profitability.

Organigram has long been a stock that was focused on the long haul and ensuring its operations and economics were as efficient as possible.

So, after the massive years-long selloff in cannabis stocks, there’s no question that if you’re looking to buy now, Organigram continues to offer some of the best value.

As pot stocks have sold off, Organigram has lost a tonne of value. In just the last 15 months, the stock has lost nearly 80% of its value. Today its market cap is just $370 million. And with a net cash position, its enterprise value (EV) is even less at just $230 million.

But to get a true understanding of how cheap Organigram is, let’s look at its valuation metrics and compare them to its competitors.

How cheap is Organigram stock?

Right now, with Organigram trading ultra-cheap and with its economics improving, especially as it gains scale, the stock trades at a forward EV-to-EBITDA ratio of just 14.9 times. That’s not ultra-cheap. However, it is attractive for a long-term growth industry like cannabis.

What’s really impressive about that number, though, is that most of the stock’s competitors aren’t even expected to earn positive EBITDA next year, which means Organigram is one of the few stocks that has a meaningful forward EV-to-EBITDA ratio to help value the stock.

Because the majority of the industry is still unprofitable, the forward EV-to-sales ratio is a better measure to compare valuations amongst each other. And with Organigram stock trading at a forward EV-to-sales ratio of just 1.5 times, it’s much cheaper than almost every competitor in its industry, with some stocks like Canopy Growth trading at more than 3.3 times sales.

So, not only does Organigram’s operations and economics look more impressive, but its valuation is also a lot more compelling than its competitors.

And when you consider Organigram stock hasn’t been this cheap since September 2017, more than a year before cannabis was legalized, it’s clear that if you have the patience to wait, Organigram stock is one of the best cannabis companies to buy in this environment while it’s ultra-cheap.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Daniel Da Costa has no position in any of the stocks mentioned. The Motley Fool recommends OrganiGram Holdings.

More on Cannabis Stocks

Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.
Cannabis Stocks

Canopy Growth: Is There Budding Potential in the Cannabis Market?

Canopy Growth stock hit 52-week lows recently on news of needing to re-file on its BIoSteel business, so what now?

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

What’s Happening With Cannabis Stocks in May 2023?

Cannabis stocks were up this week, as the market began to turn, but how long will it last, and is…

Read more »

Cannabis smoke
Cannabis Stocks

Are Cannabis Stocks a Good Buy in May 2023?

If you're going to buy cannabis stocks, these are pretty much the only two I would consider. Even so, you…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Aurora Cannabis: Time to Light Up Your Portfolio?

Here's my take on whether Aurora Cannabis (TSX:ACB) is worth adding to a growth portfolio right now, given its growth…

Read more »

Target. Stand out from the crowd
Tech Stocks

These Undervalued TSX Stocks Are a Bargain in May 2023

If you're willing to bet on a rebound, these are the three TSX stocks I would consider first as they…

Read more »

A cannabis plant grows.
Cannabis Stocks

Tilray Stock Is Scraping 52-Week Lows: Will it Bottom Out Soon?

Tilray (TSX:TLRY) stock remains down 53% in the last year, but when will this company hit the bottom and start…

Read more »

Medicinal research is conducted on cannabis.
Metals and Mining Stocks

2 Canadian Stocks That Are Simply Too Cheap to Avoid

These two Canadian stocks have sunk lower and lower, which is why now could be the right time for long-term…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

1 Marijuana Stock I’d Buy Over Aurora Cannabis

Explore a promising marijuana stock that outshines Aurora Cannabis. Unveil the investment opportunity to boost your cannabis portfolio.

Read more »